Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis

INTRODUCTION: Roxadustat treatment in PD patients is equivalent to ESAs in increasing hemoglobin (Hb). But blood pressure, cardiovascular parameters, cardio-cerebrovascular complications and prognosis in the two groups before and after treatment has not been sufficiently discussed. METHODS: Sixty PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shuiqin, Zhou, Tingting, Yu, Le, Zhang, Zhihong, Chen, Yunmin, Zhang, Man, Cui, Jingjing, Yu, Wenxin, Zhou, Jian, Yu, Yusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287021/
https://www.ncbi.nlm.nih.gov/pubmed/37359013
http://dx.doi.org/10.3389/fmed.2023.1166024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287021/
https://www.ncbi.nlm.nih.gov/pubmed/37359013
http://dx.doi.org/10.3389/fmed.2023.1166024

Ejemplares similares